Cellectar Biosciences Announces Tranche A Warrants Fully Exe

FLORHAM PARK, N.J., Jan. 25, 2024 -- Cellectar Biosciences, Inc. , a late-stage clinical biopharmaceutical company focused on the discovery, development and commercialization of drugs for the...

Related Keywords

United States , Cellectar Biosciences , James Caruso , Claire Lacagnina , Exchange Commission , Cellectar Biosciences Inc , Linkedin , Globenewswire Inc , Facebook , Nasdaq , Bliss Bio Health , Twitter , New Drug Application , Phospholipid Drug Conjugate , Markets ,